Status:
COMPLETED
Quantitative Evaluation of the Breast's Morphological Variations During Radiotherapy: MorphoBreast3D
Lead Sponsor:
Centre Paul Strauss
Conditions:
Breast Cancer Female
Adjuvant Radiotherapy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Quantitative evaluation of the breast's morphological variations during radiotherapy consisting in performing three-dimensional surface acquisitions of the breast in order to study its shape and volum...
Eligibility Criteria
Inclusion
- Women
- In situ or invasive breast carcinoma
- Treated by conservative breast surgery
- Pre-treatment with authorized chemotherapy
- Eligible for conventional breast irradiation in 25 sessions of 2 Gy with or without irradiation of the tumor bed and lymph nodes area
- Conventional 3D radiotherapy technique
- Bra cup size from A to D included
- Speaking and understanding french
- Having given written consent
- Patient with health insurance
Exclusion
- Surgical treatment by mastectomy
- No indication for breast radiotherapy
- Local or diffuse inflammatory state of the breast at inclusion
- History of epilepsy or anticonvulsive treatment for preventive or curative purposes
- BMI\> 30kg / m2
- T4 stage tumor
- Bilateral breast tumor
- Use of a ventilatory control to treat the patient
- Minor patient or major incompetent
- Patient deprived of liberty
- Patient under safeguard of justice
Key Trial Info
Start Date :
February 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 7 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03801850
Start Date
February 22 2018
End Date
May 7 2020
Last Update
August 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre paul Strauss
Strasbourg, France, 67065